Diagnostic and therapeutic recommendations for mucous membrane pemphigoid of the eye;Empfehlungen zu diagnostik und therapie beim schleimhautpemphigoid* am auge

Klinische Monatsblatter fur Augenheilkunde

Volumn 222, Issue 9, 2005, Pages 689-703

  Heiligenhaus, Arnd ^a   Bonsmann, G ^b   Heinz, C ^a   Schneider, S ^b   Zierhut, M ^c   Behrens Baumann, W ^d  

^a ST FRANZISKUS HOSPITAL   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^d UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Conjunctivitis; Keratitis; Mucous membrane pemphigoid; Ocular cicatricial pemphigoid

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; BOTULINUM TOXIN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DAPSONE; HLA ANTIGEN; IMMUNOGLOBULIN; METHOTREXATE; MITOMYCIN C; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OFLOXACIN; PREDNISONE; SULFALAZINE; SULFAPYRIDINE; TACROLIMUS;

CATARACT EXTRACTION; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONJUNCTIVITIS; CORNEA DISEASE; CORNEA LIMBUS; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DRUG CONTRAINDICATION; GLAUCOMA; GLAUCOMA SURGERY; HLA TYPING; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; INCIDENCE; INFECTION PREVENTION; KERATITIS; KERATOPLASTY; KERATOPROSTHESIS; MUCOUS MEMBRANE PEMPHIGOID; MUCOUS MEMBRANE PEMPHIGOID OF THE EYE; PATHOPHYSIOLOGY; PREVALENCE; PROGNOSIS; REVIEW; SCAR FORMATION; SYMPTOM; SYSTEMATIC REVIEW; TRICHIASIS; VISUAL IMPAIRMENT;

CHRONIC DISEASE; CONJUNCTIVITIS; DISEASE PROGRESSION; HUMANS; KERATITIS; PEMPHIGOID, BENIGN MUCOUS MEMBRANE; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; PROGNOSIS; TREATMENT OUTCOME; VISION DISORDERS;

EID: 26244467875     PISSN: 00232165     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-858455     Document Type: Review

References (116)

1. Acquavella JV, Rao GN, Brown AC et al. Keratoprosthesis. Results, complications and management. Ophthalmology 1982; 89: 655-660
2. Ahmed AR, Hombal SM. Cicatricial pemphigoid. Int J Dermatol 1986; 25: 90-96
3. Ahmed AR, Foster CS, Zaltas M et al. Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid. Proc Natl Acad Sci USA 1991; 88: 11579-11582
4. Ahmed AR, Dahl MV. Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases. Arch Dermatol 2003; 139: 1051-1059
5. Aultbrinker EA, Starr MB, Donnenfeld ED. Linear IgA Disease. The ocular manifestations. Ophthalmology 1988; 95: 340-343
6. Barabino S, Rolando M, Bentivoglio G et al. Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid. Ophthalmology 2003; 110: 474-480
7. Bean SF, Halubar K, Gillett RB. Pemphigus involving the eyes. Arch Dermatol 1975; 111: 1484-1486
8. Bernauer W, Wright P, Dart JK et al. The conjunctiva in acute and chronic mucous membrane pemphigoid. An immunohistochemical analysis. Ophthalmology 1993; 100: 339-346
9. Bhol K, Mohimen A, Neuman R et al. Differences in the anti-basement membrane zone antibodies in ocular and pseudoocular cicatricial pemphigoid. Curr Eye Res 1996; 15: 521-532
10. Boulinguez S, Bedane C, Prost C et al. Chronic pemphigoid gestationis: comparative clinical and immunopathological study of 10 patients. Dermatology 2003; 206: 113-119
11. Camisa S, Meisler DM. Immunobullous diseases with ocular involvement. Dermatol Clin 1992; 10: 555-570
12. Carrozzo M, Fasano ME, Broccoletti R et al. HLA-DQB1 alleles in Italian patients with mucous membrane pemphigoid predominantly affecting the oral cavity. Br J Dermatol 2001; 145: 805-808
13. Caux F, Kirtschig G, Lemarchand-Venencie F et al. IgA-epidermolysis bullosa acquisita in a child resulting in blindness. Br J Dermatol 1997; 137: 270-275
14. Chan LS, Soong HK, Foster CS et al. Ocular cicatricial pemphigoid occuring as a sequela of Stevens-Johnson syndrome. JAMA 1991; 266: 1543-1546
15. Chan LS. Mucous membrane pemphigoid. Clin Dermatol 2001; 19: 703-711
16. Chan RY, Bhol K, Tesavibul N et al. The role of antibody to human β4 integrin in conjunctival basement membrane separation: possible in vitro model for ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 1999; 40: 2283-2290
17. Chan LS, Ahmed AR, Anhalt GJ et al. The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators. Arch Dermatol 2002; 138: 370-379
18. Cosar CB, Cohen EJ, Rapuano CJ et al. Tarsorrhaphy. Clinical experience from a cornea practice. Cornea 2001; 20: 787-791
19. Dayan S, Simmons RK, Ahmed AR. Contemporary issues in the diagnosis of oral pemphigoid: a selective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 424-430
20. Delgado JC, Turbay D, Yunis EJ et al. A common major histocompatibility complex class II allele HLA-DQB1*0301 is present in clinical variants of pemphigoid. Proc Natl Acad Sci USA 1996; 93: 8569-8571
21. Doan S, Lerouic JF, Robin H et al. Treatment of ocular cicatricial pemphigoid with sulfasalazine. Ophthalmology 2001; 108: 1565-1568
22. Donnenfeld ED, Perry HD, Wallerstein A et al. Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid. Ophthalmology 1999; 106: 72-79
23. Ekong AS, Foster CS, Roque MR. Eye involvement in autoimmune blistering diseases. Clin Dermatol 2001; 19: 742-749
24. Elder MJ, Lightman S. The immunological features and pathophysiology of ocular cicatricial pemphigoid. Eye 1994: 196-199
25. Elder MJ, Bernauer W. Cryotherapy for trichiasis in ocular cicatricial pempgigoid. Br J Ophthalmol 1994; 78: 769-771
26. Elder MJ, Lightman S, Dart JKG. Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid. Br J Ophthalmol 1995; 79: 264-266
27. Elder MJ, Dart JKG, Collin R. Inferior retractor plication surgery for lower lid entropium with trichiasis in ocular cicatricial pemphigoid. Br J Ophthalmol 1995; 79: 1003-1006a
28. Elder MJ, Bernauer W, Leonard J et al. Progression of disease in ocular cicatricial pemphigoid. Br J Ophthalmol 1996; 80: 292-296
29. Elder MJ, Collin JRO. Anterior lamellar reposition and grey line split for upper lid entropium in ocular cicatricial pemphigoid. Eye 1996; 10: 439-442
30. Elder MJ, Dart JK, Lightman S. Conjunctival fibrosis in ocular cicatricial pemphigoid - the role of cytokines. Exp Eye Res 1997; 65: 165-176
31. Fern AI, Jay JL, Young H et al. Dapsone therapy for acute inflammatory phase of ocular pemphigoid. Br J Ophthalmol 1992; 76: 332-335
32. Foster CS, Wilson LA, Ekins MB. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 1982; 89: 340-353
33. Foster CS. Cicactricial pemphigoid. Trans Am Ophthalmol Soc 1986; 84: 527-663
34. Foster CS, Fong LP, Azar D et al. Episodic conjunctival inflammation after Stevens Johnson syndrome. Ophthalmology 1988; 95: 453-462
35. Foster CS, Ahmed AR. Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid. A preliminary study. Ophthalmology 1999; 106: 2136-2143
36. Geerling G, Dart JKG. Management and outcome of cataract surgery in ocular cicatricial pemphigoid. Graefe's Arch Clin Exp Ophthalmol 2000; 234: 112-118
37. Girard LJ, Hawkins RS, Nieves R et al. Keratoprothesis: a 12-year follow-up. Trans Am Acad Ophthalmol Otolaryngol 1977; 83: 252-267
38. Guide SV, Marinkovich MP. Linear IgA bullous dermatosis. Clin Dermatol 2001; 19: 719-727
39. Hall RP. The pathogenesis of dermatitis herpetiformis: recent advances. J Am Acad Dermatol 1987; 16: 1129-1144
40. Hall VC, Liesegang TJ, Kostick DA et al. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. Arch Dermatol 2003; 139: 1083-1084
41. Hallel-Halevy D, Nadelman C, Chen M et al. Epidermolysis bullosa acquisita: update and review. Clin Dermatol 2001; 19: 712-718
42. Hardy KM, Perry HO, Pingree GC. Benign mucous membrane pemphigoid. Arch Dermatol 1971; 104: 467-475
43. Hashimoto T. Recent advances in the study of the pathophysiology of pemphigus. Arch Dermatol Res 2003; 295 (Suppl 1): S2-11
44. Heiligenhaus A, Shore JW, Radin PAD et al. Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid. Ophthalmology 1993; 100: 1283-1288
45. Heiligenhaus A, Dutt J, Foster CS. Histology and immunopathology of systemic lupus erythematosus affecting the conjunctiva. Eye 1996; 10: 425-432
46. Hille K, Grabner G, Liu C et al. Standards for modified osteoodontokeratoprosthesis (OOKP) surgery according to Strampelli and Falcinelli. Cornea 2005 (im Druck)
47. Hodak E, Kremer I, David M et al. Conjunctival involvement in pemphigus vulgaris: a clinical, histopathological and immunofluorescence study. Br J Dermatol 1990; 123: 615-620
48. Holland EJ, Olsen TW, Ketcham JM et al. Topical cyclosporin A in the treatment of anterior segment inflammatory disease. Cornea 1993; 12: 413-419
49. Kaido M, Goto E, Dogru M et al. Punctal occlusion in the management of chronic Stevens-Johnson syndrome. Ophthalmology 2004; 111: 895-900
50. Kanitakis J. Indirect immunofluorescence microscopy for the serological diagnosis of autoimmune blistering skin diseases: a review. Clin Dermatol 2001; 19: 614-621
51. Kaplan I, Hodak E, Ackerman L et al. Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations. Oral Oncol 2004; 40: 553-562
52. Karpati S. Dermatitis herpetiformis: close to unravelling a disease. J Dermatol Sci 2004; 34: 83-90
53. Kirkness CM, Adams GG, Dilliy PN et al. Botulinum toxin A-induced protektive ptosis in corneal disease. Ophthalmology 1988; 95: 473-480
54. Kiyokawa C, Fujito S, Mori O et al. Bullous pemphigoid showing unusual ocular changes. Br J Dermatol 1998; 139: 693-696
55. Koizumi N, Inatomi T, Suzuki T et al. Cultivated corneal epithelial stem cell transplantation in ocular surface disorders. Ophthalmology 2001; 108: 1569-1574
56. Kozarsky AM, Knight SH, Waring GO. Clinical results with a ceramic keratoprosthesis placed through the eyelid. Ophthalmology 1987; 94: 904-911
57. Kozobolis VP, Christodoulakis EV, Tzanakis N et al. Primary deep sclerectomy versus primary deep sclerectomy with the use of mitomycin C in primary open-angle glaucoma. J Glaucoma 2002; 11: 287-293
58. Kumari S, Bhol KC, Simmons RK et al. Identification of ocular cicatricial pemphigoid antibody binding site(s) in human b4 integrin. Invest Ophthalmol Vis Sci 2001; 42: 379-385
59. Lam S, Stone MS, Goeken JA et al. Paraneoplastic pemphigus, cicatricial conjunctivitis and acanthosis nigrans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma. Ophthalmology 1992; 99: 108-113
60. Lazarova Z, Sitaru C, Zillikens D et al. Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid. J Am Acad Dermatol 2004; 51: 886-892
61. Leonard JN, Hobday CM, Haffenden GP et al. Immunofluorescent studies in ocular cicatricial pemphigoid. Br J Dermatol 1988; 118: 209-217
62. Letko E, Bhol K, Foster CS et al. Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study. Curr Eye Res 2000; 21: 646-654
63. Letko E, Ahmed AR, Foster CS. Treatment of ocular cicatricial pemphigoid with tacrolimus (FK 506). Graefes Arch Clin Exp Ophthalmol 2001; 239: 441-444
64. Letko E, Stechschulte SU, Kenyon KR et al. Amniotic membrane inlay and overlay grafting for corneal epithelial defects and stromal ulcers. Arch Ophthalmol 2001; 119: 659-663
65. Letko E, Miserocchi E, Daoud YJ et al. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clin Immunol 2004; 111: 303-310
66. Lever WF. Pemphigus and pemphigoid. J Am Acad Dermatol 1979; 1: 2-31
67. Leverkus M, Bhol K, Hirako Y et al. Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180 and bullous pemphigoid 230. Br J Dermatol 2001; 145: 998-1004
68. McCluskey P, Chang JH, Singh R et al. Methotrexate therapy for ocular cicatricial pemphigoid. Ophthalmology 2004; 111: 796-801
69. Meyers SJ, Varley GA, Meisler DM et al. Conjunctival involvement in paraneoplastic pemphigus. Am J Ophthalmol 1992; 114: 621-624
70. Miserocchi E, Baltatzis S, Roque MR et al. The effect of treatment and its related side effect in patients with severe ocular cicatricial pemphigoid. Ophthalmology 2002; 109: 111-118
71. Mondino BJ, Brown SI. Ocular cicatricial pemphigoid. Ophthalmology 1981: 88: 95-100
72. Mondino BJ, Brown SI. Immunosuppressive therapy in ocular cicatricial pemphigoid. Am J Ophthalmol 1983; 96: 453-459
73. Mondino BJ. Cicatricial pemphigoid and erythema multiforme. Ophthalmology 1990; 97: 939-952
74. Naumann GOH, Lang GK, Rummelt V et al. Autologous nasal mucosa transplantation in severe bilateral conjunctival mucus deficiency syndrome. Ophthalmology 1990; 97: 1011-1017
75. Neudorfer M, Sadetzki S, Anisimova S et al. Nonpenetrating deep sclerectomy with use of adjunctive mitomycin C. Ophthalmic Surg Lasers Imaging 2004; 35: 6-12
76. Neumann R, Tauber J, Foster CS. Remission and recurrence after withdrawal of therapy for ocular cicatricial pemphigoid. Ophthalmology 1991; 98: 858-862
77. Nobe JR, Moura BT, Robin JB et al. Results of penetrating keratoplasty for the treatment of corneal perforations. Arch Ophthalmol 1990; 108: 939-941
78. Noble BA, Loh RS, MacLennan S et al. Comparison of autologous serum eye drops with conventional therapy in a randomized controlled crossover trial for ocular surface disease. Br J Ophthalmol 2004; 88: 647-652
79. Patten JT, Cavanagh HD, Allansmith MR. Induced ocular pseudopemphigoid. Am J Ophthalmol 1976; 82: 272-276
80. Poon AC, Geerling G, Dart JK et al. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001; 85: 1188-1197
81. Power WJ, Neves RA, Rodriguez A et al. Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid. Ophthalmology 1995; 102: 1158-1163
82. Pouliquen Y, Patey A, Foster CS. Drug-induced cicatricial pemphigoid affecting the conjunctiva. Ophthalmology 1986; 93: 775-781
83. Reacher MH, Munoz B, Alghassany A et al. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol 1992; 110: 667-674
84. Reinhard T, Reis A, Mayweg S et al. Lokales FK 506 bei entzündlichen Erkrankungen von Hornhaut und Bindehaut. Klin Monatsbl Augenheilk 2002; 219: 125-131
85. Reis A, Reinhard T, Sundmacher R et al. Mycophenolate mofetil in ocular immunological disorders. A survey of the literature and 3 case reports. Klin Monatsbl Augenheilk 1998; 213: 257-261
86. Rice BA, Foster CS. Immunopathology of cicatricial pemphigoid affecting the conjunctiva. Ophthalmology 1990; 97: 1476-1483
87. Rogers RS, Seehafer JR, Perry O. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dematol 1982; 6: 215-223
88. de la Sainz Maza M, Tauber J, Foster CS. Cataract surgery in ocular cicatricial pemphigoid. Ophthalmology 1988; 95: 481-486
89. Sami N, Letko E, Androudi S et al. Intravenous immunoglobulin therapy in patients with ocular cicatricial pemphigoid. A long-term follow-up. Ophthalmology 2004; 111: 1380-1382
90. Secchi AG, Tognon MS. Intraoperative mitomycin C in the treatment of cicatricial obliterations of conjunctival fornices. Am J Ophthalmol 1996; 122: 728-730
91. Setterfield J, Theron J, Vaughan RW et al. Mucous membrane pemphigoid: HLA-DBQ1*0301 is associated with all clinical sites of involvement and may be linked to antibasement membrane IgG production. Br J Dermatol 2001; 145: 406-414
92. Situra C, Goebeler M, Zillikens D. Bullöse Autoimmundermatosen (I): Pathogenese und Diagnostik. JDDG 2004; Band 2: 123-139
93. Sharif KW, Arafat AF, Wykes WC. The treatment of recurrent trichiasis with argon laser photocoagulation. Eye 1991; 5: 591-595
94. Shimazaki J, Aiba M, Goto E et al. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology 2002; 109: 1285-1290
95. Shore JW, Foster CS, Westfall CT et al. Results of buccal mucosal grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology 1992; 99: 383-395
96. Solomon A, Ellies P, Anderson DF et al. Long-term outcome of kerato-limbal allograft with and without penetrating keratoplasty for total limbal stem cell deficiency. Ophthalmology 2002; 109: 1159-1166
97. Solomon A, Meller D, Prabhasawat P et al. Amniotic membrane grafts for nontraumatic corneal perforations, descemetoceles, and deep ulcers. Ophthalmology 2002; 109: 694-703b
98. Solomon A, Espana EM, Tseng SCG. Amniotic membrane transplantation for reconstruction of the conjunctival fornices. Ophthalmology 2003; 110: 93-100
99. Tauber J, Melamed S, Foster CS. Glaucoma in patients with ocular cicatricial pemphigoid. Ophthalmology 1989; 96: 33-37
100. Tauber J, de la Sainz Maza M, Foster CS. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea 1991; 10: 185-195
101. Tauber J, Jabbur N, Foster CS. Improved detection of disease progression in ocular cicatricial pemphigoid. Cornea 1992; 5: 446-451
102. Thorne JE, Anhalt GJ, Jabs DA. Mucous membrane pemphigoid and pseudopemphigoid. Ophthalmology 2004; 111: 45-52
103. Thornhill M, Pemberton M, Buchanan J et al. An open clinical trial of sulphamethoxypyridazine in the treatment of mucous membrane pemphigoid. Br J Dermatol 2000; 143: 117-126
104. Tyagi S, Bhol K, Natarajan K et al. Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proc Natl Acad Sci USA 1996; 93: 14714-14719
105. Tseng SC, Prabhasawat P, Lee SH. Amniotic membrane transplantation for conjunctival surface reconstruction. Am J Ophthalmol 1997; 124 (6): 765-774
106. Tseng SC, Prabhasawat P, Barton K et al. Amniotic membrane transplantation with or without limbal allografs for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Opthalmol 1998; 116 (4): 431-441
107. Tsubota K, Satake Y, Ohyama M et al. Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome. Am J Ophthalmol 1996; 122: 38-52
108. Tsubota K, Goto E, Shimmura S et al. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999; 106: 1984-1989
109. Tsubota K, Goto E, Fujita H et al. Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol 1999; 83: 390-395
110. Tugal-Tutkun I, Akova YA, Foster CS. Penetrating keratoplasty in cicatrizing conjunctival diseases. Ophthalmology 1995; 102: 576-585
111. Venning VA, Frith PA, Bron AJ et al. Mucosal involvement in bullous and cicatricial pemphigoid. A clinical and immunopathological study. Br J Dermatol 1988; 118: 7-15
112. Wood JR, Anderson RL. Complications of cryosurgery. Arch Ophthalmol 1981; 99: 460-463
113. Yaghouti F, Nouri M, Abad JC et al. Keratoprosthesis: preoperative prognostic categories. Cornea 2001; 20: 19-23
114. Yunis JJ, Mobini N, Yunis EJ et al. Common major histocompatibility complex II markers in clinical variants of cicatricial pemphigoid. Proc Natl Acad Sci USA 1994; 91: 7747-7751
115. Zierhut M, Thiel HJ, Weidle EG et al. Ocular involvement in epidermolysis bullosa acquisita. Arch Ophthalmol 1989; 107: 398-401
116. Zurdel J, Aboalchamat B, Zierhut M et al. Erste klinische Erfahrungen mit Mycophenolatmofetil bei der immunsuppressiven Therapie des okulären Pemphigoides. Klin Monatsbl Augenheilk 2001; 218: 222-228